Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$67.99M
↑ 185% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-79.88M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $67.99M | +267.1% |
| 2024 | $-40.69M | -74.0% |
| 2023 | $-23.38M | +68.1% |
| 2022 | $-73.27M | +71.0% |
| 2021 | $-253.02M | -128.6% |
| 2020 | $-110.70M | +58.1% |
| 2019 | $-264.10M | -166.5% |
| 2018 | $-99.10M | -71.5% |
| 2017 | $-57.78M | -204.6% |
| 2016 | $55.24M | - |